BIRC5 and cancer: The small molecule PZ-6-QN has been tested in several cancer cell lines, including MCF-7 (breast cancer) and HCT-116 (colon cancer), and has been shown to inhibit the interaction between survivin and the second mitochondrial-derived activator of caspase (Smac) (102).